DERMA SCIENCES INC's ticker is DSCI and the CUSIP is 249827502. A total of 1 filers reported holding DERMA SCIENCES INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $1,839,000 | +11.3% | 353,718 | 0.0% | 1.62% | +40.4% |
Q3 2016 | $1,652,000 | +18.5% | 353,718 | 0.0% | 1.15% | +4.2% |
Q2 2016 | $1,394,000 | +27.1% | 353,718 | 0.0% | 1.10% | +16.8% |
Q1 2016 | $1,097,000 | -32.1% | 353,718 | 0.0% | 0.95% | -34.4% |
Q4 2015 | $1,616,000 | -3.9% | 353,718 | -0.9% | 1.44% | -13.6% |
Q3 2015 | $1,681,000 | -37.2% | 356,918 | -4.5% | 1.67% | -26.3% |
Q2 2015 | $2,677,000 | -15.5% | 373,918 | 0.0% | 2.26% | -6.9% |
Q1 2015 | $3,167,000 | -11.6% | 373,918 | -2.8% | 2.43% | -14.2% |
Q4 2014 | $3,582,000 | +11.8% | 384,794 | 0.0% | 2.83% | -12.3% |
Q3 2014 | $3,205,000 | -27.9% | 384,794 | 0.0% | 3.23% | -23.3% |
Q2 2014 | $4,448,000 | -8.8% | 384,794 | 0.0% | 4.22% | +0.5% |
Q1 2014 | $4,879,000 | +690.8% | 384,794 | +575.0% | 4.19% | +560.3% |
Q4 2013 | $617,000 | -12.6% | 57,009 | 0.0% | 0.64% | -17.6% |
Q3 2013 | $706,000 | -7.2% | 57,009 | 0.0% | 0.77% | -30.8% |
Q2 2013 | $761,000 | – | 57,009 | – | 1.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 373,918 | $2,677,000 | 2.26% |
Perceptive Advisors | 348,784 | $24,997,000 | 1.50% |
Consonance Capital Management LP | 1,760,649 | $12,606,000 | 1.27% |
Broadfin Capital, LLC | 2,317,489 | $16,593,000 | 0.89% |
GREAT POINT PARTNERS LLC | 280,000 | $2,005,000 | 0.78% |
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 300,000 | $2,148,000 | 0.75% |
ROANOKE ASSET MANAGEMENT CORP/ NY | 273,926 | $1,961,000 | 0.63% |
Senvest Management, LLC | 1,152,626 | $8,253,000 | 0.52% |
J. Goldman & Co LP | 622,500 | $4,457,000 | 0.27% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 968,881 | $6,937,000 | 0.23% |